Predicting durable responses to immune checkpoint inhibitors in non-small-cell lung cancer using a multi-feature model

HIGHLIGHTS

• who: Lei Wang from the University Hospital Erlangen, Germany have published the research: Predicting Durable Responses to Immune Checkpoint Inhibitors in Non-Small-Cell Lung Cancer Using a Multi-Feature Model, in the Journal: (JOURNAL)
• what: In this study, a comprehensive analysis of NSCLC samples was carried out to investigate the role of a multi-feature model composed of TMB, ITH, and HLA LOH in determining the response to ICIs. The study showed that the accuracy of this multi-feature model was higher than that of any single biomarker, and the mPFS and mOS of . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or E-mail:

  If you don't have an account, you can create one here.